Q51.811

Clinical Causes: Genetic factors: Mutations or inherited conditions that affect the development of the reproductive organs. Developmental issues during fetal growth: Disruptions in the normal formation of the uterus in utero. Environmental exposures: Maternal exposure to certain medications or harmful substances during pregnancy. Other congenital syndromes: Conditions such as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome are associated with uterine hypoplasia.

Key Symptoms: Absence of menstruation (amenorrhea) in women of reproductive age. Infertility or difficulty conceiving. Presence of normal, immature, or underdeveloped uterine tissue on imaging studies. Possible pelvic discomfort or abnormal menstrual cycles.

Diagnosis Path: Pelvic ultrasound: Provides detailed images of uterine size and structure. Magnetic Resonance Imaging (MRI): Offers a clear view of reproductive anatomy to confirm underdevelopment. Hysterosalpingography (HSG): An imaging technique that evaluates the uterine cavity and fallopian tubes. Physical examination and medical history review to assess reproductive function.

Treatment Protocols: Hormonal therapies: May help induce menstruation if appropriate. Surgical intervention: Procedures like uterine augmentation are rarely performed, but in some cases, reconstructive surgery may be considered. Fertility assistance: Treatments such as in vitro fertilization (IVF) with a surrogate uterus might be options for women wishing to carry a pregnancy. Psychological support: Counseling services can assist with emotional aspects related to infertility and reproductive health challenges.